SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

24 Jan 2025 Evaluate
Net sales declined -14.45%  to  Rs. 8421.96 million from Rs. 9844.85 millions.A big decline of -36.86% was reported for the quarter ended December 2024 to Rs. 901.11  millions from Rs. 1427.05 millions of corresponding previous quarter.Operating profit for the quarter ended December 2024 decreased to 1734.78 millions as compared to 2475.50 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 8421.96 9844.85 -14.45 22621.37 28149.00 -19.64 37550.91 39312.00 -4.48
Other Income 56.07 6.66 741.89 101.95 23.52 333.46 57.77 99.32 -41.83
PBIDT 1734.78 2475.50 -29.92 4580.84 6144.31 -25.45 8071.37 8481.71 -4.84
Interest 172.14 197.79 -12.97 492.93 522.13 -5.59 719.98 386.74 86.17
PBDT 1562.64 2277.71 -31.39 4087.91 5622.18 -27.29 7351.39 8094.97 -9.19
Depreciation 376.63 361.59 4.16 1082.57 1074.38 0.76 1438.48 1455.57 -1.17
PBT 1186.01 1916.12 -38.10 3005.34 4547.80 -33.92 5912.91 6639.40 -10.94
TAX 284.90 489.07 -41.75 752.52 1160.78 -35.17 1553.73 1651.55 -5.92
Deferred Tax 16.54 34.50 -52.06 41.91 81.89 -48.82 47.68 -50.51 -194.40
PAT 901.11 1427.05 -36.86 2252.82 3387.02 -33.49 4359.18 4987.85 -12.60
Equity 242.49 242.37 0.05 242.49 242.37 0.05 242.37 242.04 0.14
PBIDTM(%) 20.60 25.15 -18.08 20.25 21.83 -7.23 21.49 21.58 -0.37

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×